| Scott W Mcguinness, MD | |
|
4545 Cordata Pkwy, Bellingham, WA 98226-7123 | |
| (360) 738-2200 | |
| (360) 752-5678 |
| Full Name | Scott W Mcguinness |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 4545 Cordata Pkwy, Bellingham, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205832292 | NPI | - | NPPES |
| 46515 | Other | WA | REGENCE |
| 0230381 | Other | WA | L&I AND CRIME VICTIMS |
| 1205832292 | Medicaid | WA | |
| 4586624 | Other | WA | AETNA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MD00025117 (Washington) | Primary |
| Entity Name | Peacehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356309553 PECOS PAC ID: 9537073960 Enrollment ID: O20031118001062 |
News Archive
Researchers from the University of Southampton have shown that cartoons could be a beneficial way of educating patients and empowering them to cope better with their long term conditions.
A real-world study of the characteristics of second treated eyes in patients with neovascular age-related macular degeneration given ranibizumab in the UK National Health Service has shown that these eyes start off with better baseline visual acuity than first treated eyes and, despite a poor response to therapy, maintain this advantage.
The Children's Hospital of Philadelphia today announced that it has received a pledge of $10 million over the next three years from the Foundation for a Healthy America, a non-profit entity created by the non-alcoholic beverage industry.
Sofie Biosciences, Inc., offering a comprehensive range of products from pre-clinical PET imaging systems to new PET molecular imaging probes to better understand human disease, has been told that a U.S. Patent (8,101,740) will be granted by the United States Patent Office on technology that has been exclusively licensed to Sofie. The patent covers a family of novel PET probes, known as [18F]FAC.
The c-Fos oncogene has traditionally been linked to cellular activities related to cancer, such as cell division, differentiation-conversion from one cell type to another-or survival. Any alteration of these activities can set off the development of tumours, which has made c-Fos an important target for the understanding and treatment of cancer.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Scott W Mcguinness, MD Po Box 5096, Bellingham, WA 98227-5096 Ph: (360) 738-2200 | Scott W Mcguinness, MD 4545 Cordata Pkwy, Bellingham, WA 98226-7123 Ph: (360) 738-2200 |
News Archive
Researchers from the University of Southampton have shown that cartoons could be a beneficial way of educating patients and empowering them to cope better with their long term conditions.
A real-world study of the characteristics of second treated eyes in patients with neovascular age-related macular degeneration given ranibizumab in the UK National Health Service has shown that these eyes start off with better baseline visual acuity than first treated eyes and, despite a poor response to therapy, maintain this advantage.
The Children's Hospital of Philadelphia today announced that it has received a pledge of $10 million over the next three years from the Foundation for a Healthy America, a non-profit entity created by the non-alcoholic beverage industry.
Sofie Biosciences, Inc., offering a comprehensive range of products from pre-clinical PET imaging systems to new PET molecular imaging probes to better understand human disease, has been told that a U.S. Patent (8,101,740) will be granted by the United States Patent Office on technology that has been exclusively licensed to Sofie. The patent covers a family of novel PET probes, known as [18F]FAC.
The c-Fos oncogene has traditionally been linked to cellular activities related to cancer, such as cell division, differentiation-conversion from one cell type to another-or survival. Any alteration of these activities can set off the development of tumours, which has made c-Fos an important target for the understanding and treatment of cancer.
› Verified 1 days ago
Mara Wells Kelley, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4545 Cordata Pkwy, Bellingham, WA 98226 Phone: 360-738-2200 Fax: 360-752-5678 | |
Nancy K Bischoff, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 4545 Cordata Pkwy, Bellingham, WA 98226 Phone: 360-738-2200 | |
Steven F. Wallace, M.D.,PH.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 4545 Cordata Pkwy, Bellingham, WA 98226 Phone: 360-738-2200 Fax: 360-752-5679 | |
Julianne Elise Edwards, Pediatrics Medicare: Medicare Enrolled Practice Location: 2901 Squalicum Pkwy, Bellingham, WA 98225 Phone: 360-738-2200 Fax: 360-752-5683 | |
James J. Bochsler, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 4545 Cordata Pkwy, Bellingham, WA 98226 Phone: 360-738-2200 Fax: 360-715-2486 | |
Jennifer L. Rosquist, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 4545 Cordata Pkwy Ste 1f, Bellingham, WA 98226 Phone: 360-752-5246 Fax: 360-752-5679 |